Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Effect of phyllanthus niruri on metabolic parameters of patients with kidney stone: a perspective for disease prevention.

Pucci ND, Marchini GS, Mazzucchi E, Reis ST, Srougi M, Evazian D, Nahas WC.

Int Braz J Urol. 2018 Jul-Aug;44(4):758-764. doi: 10.1590/S1677-5538.IBJU.2017.0521.

2.

Vascular Disease and Kidney Stones: Abdominal Aortic Calcifications Are Associated with Low Urine pH and Hypocitraturia.

Patel ND, Ward RD, Calle J, Remer EM, Monga M.

J Endourol. 2017 Sep;31(9):956-961. doi: 10.1089/end.2017.0350. Epub 2017 Jul 7.

PMID:
28605936
3.

Low Bone Density and Bisphosphonate Use and the Risk of Kidney Stones.

Prochaska M, Taylor E, Vaidya A, Curhan G.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1284-1290. doi: 10.2215/CJN.01420217. Epub 2017 Jun 2.

4.

Calculated insulin resistance correlates with stone-forming urinary metabolic changes and greater stone burden in high-risk stone patients.

Tran TY, Flynn M, O'Bell J, Pareek G.

Clin Nephrol. 2016 Jun;85(6):316-20. doi: 10.5414/CN108832.

PMID:
27125629
5.

Calcium and vitamin D supplementation and risk of kidney stone formation in postmenopausal women.

Haghighi A, Samimagham H, Gohardehi G.

Iran J Kidney Dis. 2013 May 21;7(3):210-3.

6.

Comparison of 24-hour urinary citrate excretion in stone formers and healthy volunteers.

Goodarzi MT, Forouzanfar F, Moaddab AH, Karimian M, Sabzevar NK.

Saudi J Kidney Dis Transpl. 2012 Nov;23(6):1227-31. doi: 10.4103/1319-2442.103564.

7.

Unilateral hypercalciuria: a stealth culprit in recurrent ipsilateral urolithiasis in children.

Tasian GE, Ziemba J, Casale P.

J Urol. 2012 Dec;188(6):2330-5. doi: 10.1016/j.juro.2012.08.035. Epub 2012 Oct 22.

8.

Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis.

Arrabal-Polo MA, Arrabal-Martin M, de Haro-Muñoz T, Poyatos-Andujar A, Palæo-Yago F, Zuluaga-Gomez A.

Urology. 2012 Jan;79(1):48-54. doi: 10.1016/j.urology.2011.07.1382. Epub 2011 Sep 9.

PMID:
21908029
9.

Clinically insignificant residual fragments after percutaneous nephrolithotomy: medium-term follow-up.

Altunrende F, Tefekli A, Stein RJ, Autorino R, Yuruk E, Laydner H, Binbay M, Muslumanoglu AY.

J Endourol. 2011 Jun;25(6):941-5. doi: 10.1089/end.2010.0491. Epub 2011 May 20.

PMID:
21599528
10.

Long-term treatment with potassium citrate and renal stones in medullary sponge kidney.

Fabris A, Lupo A, Bernich P, Abaterusso C, Marchionna N, Nouvenne A, Gambaro G.

Clin J Am Soc Nephrol. 2010 Sep;5(9):1663-8. doi: 10.2215/CJN.00220110. Epub 2010 Jun 24.

11.

Jejunoileal bypass reversal: effect on renal function, metabolic parameters and stone formation.

Dhar NB, Grundfest S, Jones JS, Streem SB.

J Urol. 2005 Nov;174(5):1844-6; discussion 1846.

PMID:
16217311
12.

Dietary risk factors for hyperoxaluria in calcium oxalate stone formers.

Siener R, Ebert D, Nicolay C, Hesse A.

Kidney Int. 2003 Mar;63(3):1037-43.

13.

Durability of the medical management of cystinuria.

Pietrow P, Auge BK, Weizer AZ, Delvecchio FC, Silverstein AD, Mathias B, Albala DM, Preminger GM.

J Urol. 2003 Jan;169(1):68-70.

PMID:
12478105
14.

Adequacy of a single stone risk analysis in the medical evaluation of urolithiasis.

Pak CY, Peterson R, Poindexter JR.

J Urol. 2001 Feb;165(2):378-81.

PMID:
11176377
15.

High sodium chloride intake is associated with low bone density in calcium stone-forming patients.

Martini LA, Cuppari L, Colugnati FA, Sigulem DM, Szejnfeld VL, Schor N, Heilberg IP.

Clin Nephrol. 2000 Aug;54(2):85-93.

PMID:
10968683
16.

When and how to evaluate a patient with nephrolithiasis.

Rivers K, Shetty S, Menon M.

Urol Clin North Am. 2000 May;27(2):203-13.

PMID:
10778464
17.

Effects of low animal protein or high-fiber diets on urine composition in calcium nephrolithiasis.

Rotily M, Léonetti F, Iovanna C, Berthezene P, Dupuy P, Vazi A, Berland Y.

Kidney Int. 2000 Mar;57(3):1115-23.

18.

Metabolic evaluation of stone disease patients: a practical approach.

Lifshitz DA, Shalhav AL, Lingeman JE, Evan AP.

J Endourol. 1999 Nov;13(9):669-78. Review.

PMID:
10608520
19.

[Nephrolithiasis--rational etiological assessment].

Hess B, Ackermann D.

Praxis (Bern 1994). 1997 Mar 25;86(13):529-32. German.

PMID:
9157499
20.

When should patients with symptomatic urinary stone disease be evaluated metabolically?

Norman RW, Bath SS, Robertson WG, Peacock M.

J Urol. 1984 Dec;132(6):1137-9.

PMID:
6502804

Supplemental Content

Loading ...
Support Center